Reuters logo
BRIEF-SOPHIRIS BIO PROVIDES ENROLLMENT UPDATE ON TOPSALYSIN PHASE 2B STUDY
October 2, 2017 / 12:21 PM / 2 months ago

BRIEF-SOPHIRIS BIO PROVIDES ENROLLMENT UPDATE ON TOPSALYSIN PHASE 2B STUDY

Oct 2 (Reuters) - Sophiris Bio Inc:

* SOPHIRIS BIO PROVIDES ENROLLMENT UPDATE ON TOPSALYSIN PHASE 2B STUDY IN LOCALIZED PROSTATE CANCER

* SOPHIRIS BIO INC - EXPECTS STUDY WILL BE FULLY ENROLLED BY END OF OCTOBER

* SOPHIRIS BIO INC - EXPECTS BIOPSY DATA FROM ALL PATIENTS DOSED WITH FIRST ADMINISTRATION OF TOPSALYSIN TO BE AVAILABLE LATE IN Q1 OF 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below